Pneumococcal Conjugate Vaccine (PCV 13) FAQs

Q: What is Pneumococcal disease?

A: Pneumococcal disease is an infection caused by a bacterium called streptococcus pneumoniae. Infection can result in a number of common diseases, ranging from serious diseases such as meningitis, septicaemia and pneumonia to milder but commoner infections such as sinusitis and otitis media.

Q: At what age do persons usually receive the Pneumococcal Vaccine?

A: The vaccine is given to children at 2, 4, and 6 months old. It is also recommended for persons with certain medical conditions such as those who have undergone a Splenectomy (surgical procedure to remove the spleen).

Q: What are the side effects of this vaccine?

A: As with most vaccines, side effects may include pain, tenderness or swelling at the injection site or a mild fever.

Q: Where can persons receive this vaccine?

A: The Vaccine is given to children at the Child Health clinic of their Health centre or at the Ministry of Public Health’s Vaccination Centre..

Featured Projects

Chronic Disease Control

cd1

MISSION STATEMENT

To address the top four causes of premature death in Guyana: cardiovascular diseases, cancer, diabetes and chronic respiratory diseases, ensuring a multi-sectoral, integrated approach is maintained. Learn More

Mental Health Unit

mental

Mission Statement

To promote, coordinate and implement technical activities and actions directed towards strengthening the national capacity to develop policies, plans, programs and services, thus contributing to the promotion of mental health, the reduction of the burden of the psychiatric diseases, prevention of disabilities, and the development of rehabilitation. Learn More 

Maternal and Child Health Unit

maternal

Mission Statement

To ensure that women, children and family members obtain maximum health care that is necessary for their growth and development. Learn More

Resources

  • PAHO/WHO Reports
  • Strategies
  • Action plans
  • Legislation
  • Training Programmes Application
  • Information, Education and Communication Materials
  • Press Releases
  • Advisories